Loading clinical trials...
Loading clinical trials...
To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT07325292 · Multiple Sclerosis
NCT05748015 · Multiple Sclerosis
NCT06433765 · Multiple Sclerosis
NCT07466823 · Multiple Sclerosis, Spasticity, and more
NCT04876339 · Parkinson Disease, Stroke, and more
CHU Nimes
Nîmes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions